Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas. | Nat Commun | 2023 | 36914652 | PubTator, text mining | PubMed |
| From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors. | Eur J Med Chem | 2023 | 36898329 | PubTator, text mining | PubMed |
| Regulation of inflammatory genes in decidual cells: Involvement of the bromodomain and extra-terminal family proteins. | PLoS One | 2023 | 36897880 | PubTator, text mining | PubMed |
| mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer. | JCI Insight | 2023 | 36883564 | PubTator, text mining | PubMed |
| Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury. | J Biomed Sci | 2023 | 36872339 | PubTator, text mining | PubMed |
| Clinical advances in epigenetic therapies for lymphoma. | Clin Epigenetics | 2023 | 36871057 | PubTator, text mining | PubMed |
| Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation. | Int Immunopharmacol | 2023 | 36857935 | PubTator, text mining | PubMed |
| The RNA binding protein DND1 is elevated in a subpopulation of pro-spermatogonia and targets chromatin modifiers and translational machinery during late gestation. | PLoS Genet | 2023 | 36857387 | PubTator, text mining | PubMed |
| Cannabinoids Transmogrify Cancer Metabolic Phenotype via Epigenetic Reprogramming and a Novel CBD Biased G Protein-Coupled Receptor Signaling Platform. | Cancers (Basel) | 2023 | 36831374 | PubTator, text mining | PubMed |
| Phage Therapy as an Alternative Treatment Modality for Resistant Staphylococcus aureus Infections. | Antibiotics (Basel) | 2023 | 36830196 | PubTator, text mining | PubMed |
| E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology. | J Med Chem | 2023 | 36821822 | PubTator, text mining | PubMed |
| Molecular classification and therapeutics in diffuse large B-cell lymphoma. | Front Mol Biosci | 2023 | 36818048 | PubTator, text mining | PubMed |
| Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions. | JAC Antimicrob Resist | 2023 | 36816746 | PubTator, text mining | PubMed |
| PBRM1 bromodomains associate with RNA to facilitate chromatin association. | Nucleic Acids Res | 2023 | 36808431 | PubTator, text mining | PubMed |
| FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. | Commun Biol | 2023 | 36805539 | PubTator, text mining | PubMed |
| Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. | Signal Transduct Target Ther | 2023 | 36797244 | PubTator, text mining | PubMed |
| Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets. | Front Endocrinol (Lausanne) | 2023 | 36793283 | PubTator, text mining | PubMed |
| Nuclear protein in testis carcinoma of the lung. | Transl Oncol | 2023 | 36780749 | PubTator, text mining | PubMed |
| Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma. | Int J Mol Sci | 2023 | 36768967 | PubTator, text mining | PubMed |
| Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer. | Mol Cancer Ther | 2023 | 36752780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=15